Taysha Gene Therapies, Inc. financial statements, including revenue, expenses, profit, and loss
The total revenue of TSHA for the last quarter is 3.60 M USD, and it's 24.06% lower compared to the previous quarter. The net income of Q4 23 is 47.74 M USD.